UP seeks pharma investments

The Government of Uttar Pradesh (UP), in collaboration with the Bulk Drugs Manufacturers’ Association of India (BDMAI) and the Indian Drug Manufacturers Association (IDMA) Telangana and Andhra Pradesh chapter on Thursday conducted a Pharma Conclave in Hyderabad.
Abhishek Prakash, the Chief Executive Officer (CEO) of Invest UP, stressed the significance of UP and its endeavours to create a favorable destination for investments in the pharma sector and provided insights into the investor-friendly industry landscape in the state, its robust infrastructure and key policy highlights, such as the UP Industrial Policy, FDI Policy, and Pharma Policy.
Mayur Maheshwari, CEO of UP State Industrial Development Authority (UPSIDA), stressed the potential of the Bulk Drug Park in Lalitpur and Med-Tech Park in the Yamuna Expressway Industrial Development Authority (YEIDA) region and informed industry leaders about the land banks available across Uttar Pradesh for setting up industries.
Awanish Kumar Awasthi, advisor to Chief Minister of UP, shed light on the State government’s vision of becoming a US$ 1 Trillion economy and briefed the senior dignitaries from the Telangana government and the pharma industry about the conducive environment that UP offers for the growth of the sector.
Dr Venkat Jasti, Chairman and CEO of Suven Life Sciences Limited, discussed the challenges in the pharma industry and emphasised on the importance of infrastructure, including common effluent treatment plants and maintaining ‘no habitat zones’ in proximity to these projects. Rajiv N of NATCO Pharma expressed interest in establishing labs in Noida.